Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Down 0.4%
Thu, 26 Sep 14:47

INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Down 0.4%Image source: ThinkNeo/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has plunged 5% and is presently trading at Rs 424.1.

Meanwhile, the BSE HEALTHCARE index is at 43,994.1 (down 0.4%).

Among the top losers in the BSE HEALTHCARE index today are Sanofi India (down 2.9%) and DR. LAL PATHLABS (down 2.8%).

FORTIS HEALTHCARE (up 2.3%) and Abbott India (up 1.9%) are among the top gainers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 169.1 to Rs 424.1, registering a gain of Rs 255.1 (up 150.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 43,994.1, registering a gain of 58.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 182.8%), SUVEN PHARMACEUTICALS (up 123.9%) and Glenmark Pharma (up 112.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 85,721.5 (up 0.6%).

The top gainers among the BSE Sensex today are Maruti Suzuki (up 4.7%) and M&M (up 3.3%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 26,189.9 (up 0.7%). Maruti Suzuki and M&M are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 85,721.5, registering a gain of 19,697.8 points (up 29.8%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.

For the year ended March 2024, INDRAPRASTHA MEDICAL reported 43.9% increase in net profit to Rs 1,240 million compared to net profit of Rs 862 million during FY23. Revenue of the company grew 13.3% to Rs 12,447 million during FY24.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 28.1.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Plunges 5%; BSE HEALTHCARE Index Down 0.4%". Click here!